HRT Financial’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

HRT Financial’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,000	Closed	-$1K	–	2490
2024 Q2	$1K	Sell	36,000 -936	-3%	-$57	﹤0.01%	2103
2024 Q1	$4K	Buy	36,936 +2,025	+6%	+$304	﹤0.01%	2116
2023 Q4	$6K	Sell	34,911 -1,089	-3%	-$108	﹤0.01%	2116
2023 Q3	$1K	Hold	36,000	–	–	﹤0.01%	2270
2023 Q2	$6K	Sell	36,000 -291	-0.8%	-$53	﹤0.01%	2213
2023 Q1	$10K	Buy	36,291 +91	+0.3%	+$21	﹤0.01%	2246
2022 Q4	$1K	Buy	36,200 +200	+0.6%	+$24	﹤0.01%	2370
2022 Q3	$4K	Hold	36,000	–	–	﹤0.01%	2608
2022 Q2	$5K	Hold	36,000	–	–	﹤0.01%	2738
2022 Q1	$7K	Buy	+36,000	New	+$8.55K	﹤0.01%	2929

Other funds holding CDIOW

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's CDIOW Position: Q3 2024 in Review

HRT Financial sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q3 2024, closing a stake of 36,000 shares — an estimated $1K sold.

HRT Financial first reported a position in CDIOW in Q1 2022 and held it in 10 quarters. The position peaked at $10K in Q1 2023. 10 funds tracked by Wall St. Rank hold CDIOW as of Q3 2024.

HRT Financial reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q3 2024 after selling out during the quarter.
HRT Financial sold 36,000 Cardio Diagnostics Holdings Inc Warrant shares in Q3 2024, an estimated $1K.
HRT Financial first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 10 quarters.
HRT Financial's Cardio Diagnostics Holdings Inc Warrant position peaked at $10K in Q1 2023.
10 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.